Measurement of brain atrophy has been proposed as a surrogate marker in MS and degenerative dementias. Although cerebral small vessel disease predominantly affects white and subcortical grey matter, recent data suggest that whole brain atrophy is also a good indicator of clinical and cognitive status in this disease. Automated methods to measure atrophy are available that are accurate and reproducible in disease-free brains. However, optimal methods in small vessel disease have not been established and the impact of ischaemic lesions on different techniques has not been explored systematically. In this study, three contrasting techniques -- Statistical Parametric Mapping 5 (SPM5), SIENAX and BrainVisa -- were applied to measure cross-sectio...
Neuroimaging is a mainstay in the differential diagnosis of patients with cognitive impairment. The ...
Neuroimaging is a mainstay in the differential diagnosis of patients with cognitive impairment. The ...
Cerebral small vessel disease (SVD) is a heterogeneous group of pathological disorders that affect t...
Measurement of brain atrophy has been proposed as a surrogate marker in MS and degenerative dementia...
Brain atrophy is increasingly evaluated in cerebral small vessel diseases. We aim at systematically ...
BACKGROUND AND PURPOSE: Brain atrophy is a proposed marker of disease progression in multiple sclero...
Brain volume loss (atrophy) is widely used as a marker of disease progression. Atrophy has been meas...
CADASIL is an arteriopathy caused by mutations of the Notch3 gene. White matter hyperintensities (WM...
Magnetic resonance imaging is an important method to diagnose and evaluate the progression of MS. SI...
International audienceCADASIL is a monogenic small vessel disease characterized by the accumulation ...
Brain volume loss (atrophy) is widely used as a marker of disease progression. Atrophy has been meas...
Background and Purpose- Cerebral small vessel disease is characterized by a wide range of focal and ...
Neuroimaging is a mainstay in the differential diagnosis of patients with cognitive impairment. The ...
Neuroimaging is a mainstay in the differential diagnosis of patients with cognitive impairment. The ...
Cerebral small vessel disease (SVD) is a heterogeneous group of pathological disorders that affect t...
Measurement of brain atrophy has been proposed as a surrogate marker in MS and degenerative dementia...
Brain atrophy is increasingly evaluated in cerebral small vessel diseases. We aim at systematically ...
BACKGROUND AND PURPOSE: Brain atrophy is a proposed marker of disease progression in multiple sclero...
Brain volume loss (atrophy) is widely used as a marker of disease progression. Atrophy has been meas...
CADASIL is an arteriopathy caused by mutations of the Notch3 gene. White matter hyperintensities (WM...
Magnetic resonance imaging is an important method to diagnose and evaluate the progression of MS. SI...
International audienceCADASIL is a monogenic small vessel disease characterized by the accumulation ...
Brain volume loss (atrophy) is widely used as a marker of disease progression. Atrophy has been meas...
Background and Purpose- Cerebral small vessel disease is characterized by a wide range of focal and ...
Neuroimaging is a mainstay in the differential diagnosis of patients with cognitive impairment. The ...
Neuroimaging is a mainstay in the differential diagnosis of patients with cognitive impairment. The ...
Cerebral small vessel disease (SVD) is a heterogeneous group of pathological disorders that affect t...